Israel's Ministry of Health to begin a Phase II clinical trial of BL-7040, an orally available molecule for treating Inflammatory Bowel Disease (IBD)...BiolineRX reported that the Phase II trial will be an open-label study to evaluate the efficacy, pharma-dynamics, safety and tolerability of...
FULL ARTICLE AT Globes Online